Pharmaceutical companies have long experience in measuring the impact of their business programs. The same should apply to their access-to-medicine efforts. Richard Laing, from the Boston University (BU) School of Public Health and former World Health Organization official, says that many efforts to expand access to medicines fail to gather sufficient evidence on how effective they are.
How can we prevent the urbanization boom from becoming a health crisis? Making our cities into places of wellbeing, exciting growth and opportunity will require every sector to join forces on urban health, says Dr. Ann Aerts, Head of the Novartis Foundation.
On World Hypertension Day 2017, the Novartis Foundation and its partners, including Intel Corporation, the NCD Alliance, city governments and local partners, announce the launch of Better Hearts Better Cities, an innovative initiative to address the high rates of high blood pressure (hypertension) in low-income urban communities.
“Big Data,” the phenomenon every industry and professional is hailing as the next great innovation-driver, has its origins in part in the healthcare industry. In today’s fast-paced environment, Big Data is likely to play an increasing role in helping hospitals stay ahead of the curve in the ever-changing healthcare industry.
Novartis reaches agreement with Pakistan to supply medicines that address the rapid rise of chronic illness among poor people in the world's sixth most populous nation. Novartis Access medicines will be made available to the poorest population in Pakistan through hospitals under the Prime Minister’s National Health Insurance Program.
Diageo, the global leader in beverage alcohol, announced today the public launch of an online e-learning module called DRINKiQ designed to provide consumers with the information they need to make informed decisions about drinking responsibly.
Gilead Sciences, Inc. today announced that it issued its Year in Review 2016, a combination of the company’s Annual Report and Corporate Social Responsibility report. This report provides an in-depth look into Gilead’s commitment to develop and deliver innovative therapies that change lives.
Cascale shares updates on its strategic partnerships with industry stakeholders geared toward shifting the industry into one that gives back more than...
Cascale shares updates on its strategic partnerships with industry stakeholders geared toward shifting the industry into one that gives back more than...
Advanced security, fraud, and data protection, Keeping your accounts and information secure is a priority for us, and we know it’s a priority for you...
Cascale shares updates from its Board of Directors who serve as the principal governing body and are responsible for setting the strategic direction...
